Literature DB >> 24855966

Antegrade joint-sparing intramedullary wiring for middle phalanx shaft fractures.

Anoop C Dhamangaonkar1, Hemant S Patankar2.   

Abstract

PURPOSE: To evaluate the outcome for surgical stabilization of middle phalanx shaft fractures with joint-sparing antegrade intramedullary K-wire fixation.
METHODS: We treated 15 extra-articular transverse or short oblique shaft fractures of the middle phalanx in 13 patients. All fractures were treated with closed reduction internal fixation with antegrade joint-sparing intramedullary K-wires. Patients had a minimum follow-up of 1 year (range, 1-10 y). We assessed the objective outcome at 6 months by calculating total active range of motion.
RESULTS: All fractures healed. Based on the total active motion score at 6 months, 10 digits showed excellent results, 3 digits were good, 1 was fair, and 1 was poor. Among 3 patients with an associated flexor tendon injury, 2 had excellent outcomes and one had a poor outcome. For 2 patients with an associated extensor tendon injury, 1 had a good outcome and the other had a fair outcome.
CONCLUSIONS: Antegrade intramedullary wiring for extra-articular transverse and short oblique shaft  fracture of middle phalanx is a simple, safe, inexpensive, and joint-sparing technique that provides enough fracture stability, even in cases of associated injuries, for early rehabilitation and functional recovery with the expectation of a good to excellent outcome. TYPE OF STUDY/LEVEL OF EVIDENCE: Therapeutic IV.
Copyright © 2014 American Society for Surgery of the Hand. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Antegrade; intramedullary; middle; phalanx; wire

Mesh:

Year:  2014        PMID: 24855966     DOI: 10.1016/j.jhsa.2014.04.017

Source DB:  PubMed          Journal:  J Hand Surg Am        ISSN: 0363-5023            Impact factor:   2.230


  1 in total

1.  Timing for Surgical Stabilization with K-wires after Open Fractures of Proximal and Middle Phalangeal Shaft.

Authors:  Yanchun Gao; Qiyang Wang; Hongyi Zhu; Zhengyu Xu
Journal:  Sci Rep       Date:  2017-09-12       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.